EPISODE · Dec 13, 2017 · 14 MIN
CEO John Maslowski of Fibrocell Science Inc. (NASDAQ: FCSC)
from Stock Day Media · host Stock Day Media
CEO John Maslowski of Fibrocell Science Inc. (NASDAQ: FCSC), joins Uptick Newswire to discuss fighting diseases with cell and gene therapies for localized treatment. NASDAQ: FCSC # Biotechnology # autologous cell and gene therapies # personalized biologic # focus on the patient # Arthritis and Related Conditions # FCX-007 # FCX-013 # fibroblasts # Gene Therapy Research Program # Localized Scleroderma # Recessive Dystrophic Epidermolysis Bullosa Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
What this episode covers
CEO John Maslowski of Fibrocell Science Inc. (NASDAQ: FCSC), joins Uptick Newswire to discuss fighting diseases with cell and gene therapies for localized treatment. NASDAQ: FCSC # Biotechnology # autologous cell and gene therapies # personalized biologic # focus on the patient # Arthritis and Related Conditions # FCX-007 # FCX-013 # fibroblasts # Gene Therapy Research Program # Localized Scleroderma # Recessive Dystrophic Epidermolysis Bullosa Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy
NOW PLAYING
CEO John Maslowski of Fibrocell Science Inc. (NASDAQ: FCSC)
No transcript for this episode yet
Similar Episodes
Sep 22, 2023 ·20m
Sep 22, 2023 ·20m
Sep 22, 2023 ·27m
Sep 22, 2023 ·14m
Sep 22, 2023 ·24m
Sep 22, 2023 ·22m